Cargando…

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?

Detalles Bibliográficos
Autores principales:	Wilson, Carole L., Hung, Chi F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444631/ https://www.ncbi.nlm.nih.gov/pubmed/30540914 http://dx.doi.org/10.1165/rcmb.2018-0387ED

Ejemplares similares

Secret Weapon in the Battle Against Cavities?
por: Damle, S. G.
Publicado: (2017)

Inhaled nitric oxide: another weapon in our armamentarium in the battle against acute hypoxic respiratory failure in preterm infants
por: Da-Silva, Shonola S, et al.
Publicado: (2004)

Little evidence for community treatment orders – a battle fought with heavy weapons
por: Heun, Reinhard, et al.
Publicado: (2016)

Molecular Imaging of Pulmonary Fibrosis: Another Step Forward
por: Montesi, Sydney B.
Publicado: (2021)

Early Prevention of Childhood Obesity: Another Promise or a Reliable Path for Battling Childhood Obesity?
por: von Kries, Rüdiger, et al.
Publicado: (2014)

The Battle against Cardiogenic Shock
por: Rahamim, Eldad, et al.
Publicado: (2022)

Mapping Non-Coding RNAs in Space and Time: Another Weapon to Dissect Intra-Tumor Heterogeneity in Cancer Progression
por: Cioce, Mario, et al.
Publicado: (2023)

COVID-19 therapy: What weapons do we bring into battle?
por: de Almeida, Sinara Mônica Vitalino, et al.
Publicado: (2020)

Drug repurposing for breast cancer therapy: Old weapon for new battle
por: Aggarwal, Sadhna, et al.
Publicado: (2021)

Battling COVID-19: using old weapons for a new enemy
por: Kumar, Rohit, et al.
Publicado: (2020)

A new weapon against an old target
por: Fiehn, Christoph
Publicado: (2011)

Cyclosporine: an old weapon in the fight against coronaviruses
por: Molyvdas, Adam, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines
por: Perego, Silvia, et al.
Publicado: (2021)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Monkeypox Outbreaks in 2022: Battling Another “Pandemic” of Misinformation
por: Ennab, Farah, et al.
Publicado: (2022)

Implanted peripheral nerve stimulator – Another weapon for managing pain
por: Sahoo, Rajendra, et al.
Publicado: (2020)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

Immunity, the God-given weapon against infection
por: Cao, Xuetao
Publicado: (2015)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

The Fight against Tuberculosis in India: A New Weapon Needed
Publicado: (1945)

India’s Battle against COVID-19: Progress and Challenges
por: Laxminarayan, Ramanan, et al.
Publicado: (2020)

The battle against perioperative glycaemic control: Hard to win?
por: Parthasarathy, S., et al.
Publicado: (2022)

Acoustic shock waves, a new weapon against angina?
por: van Hemel, N. M., et al.
Publicado: (2016)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

Battling burnout
por: The Lancet Rheumatology
Publicado: (2022)

State of the Globe: The Global Battle for Survival against Mycobacterium tuberculosis
por: Chauhan, Vivek, et al.
Publicado: (2017)

Stigma: The Stealth Weapon of the NTD
por: Hotez, Peter J.
Publicado: (2008)

Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management
por: Baldi, Bruno Guedes
Publicado: (2017)

Six-minute walk test in patients with idiopathic pulmonary fibrosis
por: Baddini-Martinez, José Antônio
Publicado: (2018)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
por: Poletti, Venerino
Publicado: (2014)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Assessing the Burden and Prognostic Value of Cough in Idiopathic Pulmonary Fibrosis
por: Johnston, Janet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qk0d1h1tfpn1p5sedvl7kh8e9n